Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
Team Leidos would like to make interested suppliers aware that it intends to tender the Over-labelled Medicinal Products requirement as part of their Pharmaceutical Products and Associated Services requirement for the Ministry of Defence in 2019, with a view to awarding one or more Contracts that will commence during 2020 for a period of up to 4 years. The requirement consists of products that fall within the scope of Pharmaceutical Products and Associated Services with a defined set of labelling requirements, which must be compliant with relevant legislation.
The appropriate licences must be held for this activity. The companies that are involved in all stages of the manufacture and distribution of the product need to have the relevant licence for the activity in question (Manufacturer's and/or Wholesale Dealer's Licences 'WDA').
Please see section II.2.4
Additional information: To view this notice, register as a supplier here:
http://www.contracts.mod.uk/delta/signup.html?userType=supplier and search for the notice with reference 'UK-Bristol: Pharmaceutical products.'.
No supplier information available.